Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study
作者： Alex Z Fu , Qiaoyi Zhang , Michael J Davies , Sri-Ram Pentakota , Larry Radican
DOI: 10.1185/03007995.2011.567257
关键词:
摘要: AbstractObjectives:To estimate the proportion of patients with type 2 diabetes who were eligible for statin treatment per American Diabetes Association (ADA) recommendations and actually prescribed a in US clinical practice. Factors associated receiving prescription also determined.Methods:Patients ≥25 years diagnosed or had received prescriptions antihyperglycemic agents between 7/2006 6/2008 identified within large electronic medical record database. Eligibility therapy was determined according to 2008 ADA recommendations. Statin use assessed based on records during 12-month follow-up period. An adjusted logistic regression analysis performed likelihood relation selected baseline characteristics.Results:Of 125,464 identified, 98.5% therapy. Only 62.9% In an ...
informahealthcare.com参考文章(22)
Päivi Ruokoniemi, Maarit J. Korhonen, Arja Helin-Salmivaara, Piia Lavikainen, Antti Jula, Seppo Y. T. Junnila, Raimo Kettunen, Risto Huupponen, Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study. British Journal of Clinical Pharmacology. ,vol. 71, pp. 766- 776 ,(2011) , 10.1111/J.1365-2125.2010.03895.X
GM Oderda, D Brixner, M Lieberman, PMC1 COMPARISON OF EMR DATA TO US NATIONAL DATA Value in Health. ,vol. 10, ,(2007) , 10.1016/S1098-3015(10)65555-6
Devin M Mann, Mark Woodward, Fen Ye, Marie Krousel-Wood, Paul Muntner, Trends in Medication Use Among US Adults With Diabetes Mellitus: Glycemic Control at the Expense of Controlling Cardiovascular Risk Factors Archives of Internal Medicine. ,vol. 169, pp. 1718- 1725 ,(2009) , 10.1001/ARCHINTERNMED.2009.296
Jennifer LY Tsang, Aurora Mendelsohn, Mary KK Tan, Daniel G Hackam, Lawrence A Leiter, David Fitchett, Peter J Lin, Etienne Grima, Anatoly Langer, Shaun G Goodman, Vascular Protection Registry, Guidelines Oriented Approach to Lipid Lowering Registry Investigators, Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy. American Journal of Cardiology. ,vol. 102, pp. 1142- 1145 ,(2008) , 10.1016/J.AMJCARD.2008.06.037
J. Stamler, O. Vaccaro, J. D. Neaton, D. Wentworth, , Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. ,vol. 16, pp. 434- 444 ,(1993) , 10.2337/DIACARE.16.2.434
V. Basevi, S. Di Mario, C. Morciano, F. Nonino, N. Magrini, Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61 Diabetes Care. ,vol. 34, ,(2011) , 10.2337/DC11-0174
Patricia M Kearney, Anthony Keech, John Simes, Rory Collins, Colin Baigent, None, Statins and diabetes – Authors' reply The Lancet. ,vol. 371, pp. 1752- 1752 ,(2008) , 10.1016/S0140-6736(08)60761-8
K. Pyörälä, , S. Lehto, D. De Bacquer, J. De Sutter, S. Sans, U. Keil, D. Wood, G. De Backer, Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys. Diabetologia. ,vol. 47, pp. 1257- 1265 ,(2004) , 10.1007/S00125-004-1438-Z
Pieter van den Haak, Edith Heintjes, Arian W. Plat, Willem Jan Meerding, Kate Webb, Miriam C. Sturkenboom, Ron M.C. Herings, Determination of non-treatment with statins of high risk patients in The Netherlands. Current Medical Research and Opinion. ,vol. 26, pp. 271- 278 ,(2010) , 10.1185/03007990903435184
Shaista Malik, Victor Lopez, Roland Chen, Wei Wu, Nathan D. Wong, Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Research and Clinical Practice. ,vol. 77, pp. 126- 133 ,(2007) , 10.1016/J.DIABRES.2006.10.016